‹ ›
MYP_071529
← PREVIOUS NEXT → BACK
Basic Information
FLAK50J
Anticancer
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
13 amino acids
C66H117N17O14
Standard
Sequence
FAKLLAKLAKKAA
Physicochemical Analysis
1372.74 Da
10.48
3.76
3.55
0.2889
0.58
0.71
0.11
-3.83
128.46
0.0769
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
516.60
-1.79
18.0
18.0
49.0
97.0
1.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0360600 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 53.8%, E 0.0%, T 15.4%, C 30.8% [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Anticancer
PaperCancerPPD: a database of anticancer peptides and proteins PMID25270878 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/25270878/
RECORD: Rec_0377341 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
FLAK peptides
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Anticancer
SW-480 (colon cancer)
MTT/MTS assay
PaperPatent US_06875744_B2 | https://patents.google.com/?q=US_06875744_B2 PatentUS_06875744_B2
FIRST PREV 1 2 3
Showing 2 records on this page · Page 3 of 3